4E Therapeutics Custom Synthesis and Medicinal Chemistry

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

McHardy Stanton

Funded by

4E Therapeutics Inc.

Research Start Date

01/01/2023

Status

Inactive

Basic Research

Collaborative Project

Basic Research

Drug Discovery

Neuroscience

Bioscience Research Panel